Frequency of Clostridium Difficile Diarrhea and Other Adverse Effects With Cefepime Versus Piperacillin-Tazobactam

Authors

Chanie Wassner
M Hudson
Sara Kamalfar
Stella Okoye
Daryl Glick
Sibte Burney
Henry Cohen, Touro College of PharmacyFollow

Document Type

Abstract

Publication Date

2015

Recommended Citation

Wassner, C., Hudson, M., Kamalfar, S., Okoye, S., Glick, D., Burney, S., . . . Cohen, H. (2015). Frequency of clostridium difficile diarrhea and other adverse effects with cefepime versus piperacillin-tazobactam. Journal of Pharmacy Practice, 28(3), 311. doi:10.1177/0897190015583953

Publisher's Statement

The original material can be found here:

https://doi:10.1177/0897190015583953